Centogene Shares Are Trading Higher After the Company Signed a Memorandum of Understanding With C-Path for Collaboration in Lysosomal Disease Research and Drug Development.
Centogene Shares Are Trading Higher After the Company Signed a Memorandum of Understanding With C-Path for Collaboration in Lysosomal Disease Research and Drug Development.
centogene簽署諒解備忘錄和c-path進行溶酶體疾病研究和藥物開發合作後，其股票價格有所上漲。
Centogene Shares Are Trading Higher After the Company Signed a Memorandum of Understanding With C-Path for Collaboration in Lysosomal Disease Research and Drug Development.
centogene簽署諒解備忘錄和c-path進行溶酶體疾病研究和藥物開發合作後，其股票價格有所上漲。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。